Suo Zhang

Xi'an, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Development and validation of a clinical risk score nomogram for predicting clozapine plasma concentrations below 350 ng/mL: A retrospective cohort study.

Development and validation of a clinical risk score nomogram for predicting clozapine plasma concentrations below 350 ng/mL: A retrospective cohort study.

Journal: British journal of clinical pharmacology

Published: August 31, 2025

Development of a nomogram risk prediction model for subtherapeutic valproic acid plasma concentration: A retrospective cohort study.

Development of a nomogram risk prediction model for subtherapeutic valproic acid plasma concentration: A retrospective cohort study.

Journal: Journal of affective disorders

Published: July 14, 2025

Analysis of factors affecting laboratory alert level of trazodone based on therapeutic drug monitoring data.

Analysis of factors affecting laboratory alert level of trazodone based on therapeutic drug monitoring data.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: March 18, 2025

Clozapine Once-Versus Multiple-Daily Dosing Regimen: A Single-Center, Retrospective, Cross-Sectional Study.

Clozapine Once-Versus Multiple-Daily Dosing Regimen: A Single-Center, Retrospective, Cross-Sectional Study.

Journal: Human psychopharmacology

Published: November 20, 2024

Daily dosing frequency as a determinant of clozapine concentration-to-dose ratio: Data from a therapeutic drug monitoring service (2019-2022).

Daily dosing frequency as a determinant of clozapine concentration-to-dose ratio: Data from a therapeutic drug monitoring service (2019-2022).

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: July 25, 2024

Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data.

Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data.

Journal: Journal of clinical psychopharmacology

Published: October 26, 2022

Usefulness of Therapeutic Drug Monitoring and Pharmacogenetics for a Patient Treated with Olanzapine, Buspirone, and Fluvoxamine: A Case Study.

Usefulness of Therapeutic Drug Monitoring and Pharmacogenetics for a Patient Treated with Olanzapine, Buspirone, and Fluvoxamine: A Case Study.

Journal: Therapeutic drug monitoring

Published: September 27, 2022

Impact of Heat Inactivation of Blood Samples on Therapeutic Drug Monitoring of 5 Second-Generation Antipsychotics and Their Metabolites.

Impact of Heat Inactivation of Blood Samples on Therapeutic Drug Monitoring of 5 Second-Generation Antipsychotics and Their Metabolites.

Journal: Therapeutic drug monitoring

Published: January 29, 2022

A novel and robust analytical method for the quantification of perospirone in human plasma using an LC-MS/MS system with self-internal standard calibration.

A novel and robust analytical method for the quantification of perospirone in human plasma using an LC-MS/MS system with self-internal standard calibration.

Journal: Clinical biochemistry

Published: September 17, 2021

Development of a Novel Analytical Method for Determining Trazodone in Human Plasma by Liquid Chromatography Coupled With Mass Spectrometry Coupled With Automatic 2-Dimensional Liquid Chromatograph-Mass Spectrometer Coupler 9500 and Its Application to Therapeutic Drug Monitoring.

Development of a Novel Analytical Method for Determining Trazodone in Human Plasma by Liquid Chromatography Coupled With Mass Spectrometry Coupled With Automatic 2-Dimensional Liquid Chromatograph-Mass Spectrometer Coupler 9500 and Its Application to Therapeutic Drug Monitoring.

Journal: Therapeutic drug monitoring

Published: March 09, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026